Dengue NS1 Antigen EIA (ELISA) Test in UAE | 270 AED | DHA-Licensed Diagnostic Laboratory

Executive Summary & Core Metrics

Your Diagnostic Assurance – Accuracy, Speed & Clinical Trust

Diagnostic Precision: >99% sensitivity and specificity for acute dengue detection using ISO 15189:2022 accredited enzyme-linked immunosorbent assay methodology.
Convenient Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM across all Emirates.
Post-Test Support: Complimentary telephonic result interpretation by a DHA-licensed general practitioner to guide your next clinical steps.
Insurance & Billing: Direct insurance verification and cashless options available via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Dengue NS1 Antigen EIA (ELISA) test identifies the non-structural protein 1 of the dengue virus during the acute febrile phase, typically before IgM antibodies become detectable. This laboratory-based immunoassay delivers quantitative optical density readings that outperform rapid immunochromatographic tests in both sensitivity and specificity, establishing it as the reference standard for early dengue diagnosis in the UAE.

Feature	ELISA / EIA Laboratory Assay	Rapid NS1 ICT (Point-of-Care)
Methodological Principle	Enzyme-linked immunosorbent assay using monoclonal antibodies; quantitative signal detection via spectrophotometry	Immunochromatographic lateral flow; qualitative visual interpretation
Diagnostic Sensitivity	>99% for NS1 antigen during first 7 days of fever	80–90% sensitivity; elevated false-negative rate in secondary infections
Turnaround Time	Same-day report when sample received before 12 noon	Immediate (15–20 minutes)

Physician Insight & Safety Protocols

“A positive NS1 antigen result by ELISA provides a reliable early marker of acute dengue infection, particularly within the first five days of fever. However, this laboratory finding must be interpreted alongside the complete blood count, platelet trend, and clinical signs such as high fever, myalgia, and retro-orbital pain. Early confirmation allows timely monitoring and reduces the risk of progression to severe dengue.”

— Dr. Ajay Singh
General Practitioner | DHA Registration ID: 36234132

Medication Advisory – Do Not Self-Adjust Treatment

Important Medication Advisory

Do not discontinue, alter, or initiate any prescription or over-the-counter medication without direct consultation with your treating physician. Self-managed changes can mask symptoms or exacerbate complications during an acute febrile illness.

Exclusion Criteria & Red Flags – When to Seek Emergency Care

Emergency Warning Signs – Seek Immediate Medical Attention

Severe abdominal pain or persistent, uncontrolled vomiting
Mucosal bleeding (gums, nose), easy bruising, or blood in vomitus or stool
Lethargy, restlessness, or sudden drowsiness
Rapid breathing, cold clammy skin, weak pulse – indicators of shock
Pregnancy with suspected dengue requires specialist-led care
Minors under 18 years must be accompanied by a legal guardian during consultation and sample collection

If any of these signs are present, proceed immediately to the nearest emergency department.

Patient FAQ & Clinical Guidance

1. What is the Dengue NS1 Antigen EIA test and how does it work?

This laboratory-based enzyme immunoassay detects the NS1 protein of the dengue virus, which is secreted into the bloodstream during the acute phase of infection. Unlike rapid tests that rely on visual interpretation, this method uses spectrophotometric measurement to deliver quantitative, highly reproducible results with superior sensitivity.

2. When should I take the Dengue NS1 test after symptoms appear?

The NS1 antigen becomes detectable as early as day one of fever and remains positive for up to nine days. For optimal diagnostic yield, the test should be performed within the first five days of symptom onset. After day five, if the NS1 antigen has cleared, your physician may recommend paired IgM and IgG serology to confirm the diagnosis.

3. Is home sample collection available for this test across the UAE?

Yes, our ISO-certified cold-chain home phlebotomy service covers Dubai, Abu Dhabi, Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, and Fujairah. A trained phlebotomist will visit your home between 8 AM and 11 PM daily, ensuring proper sample handling and temperature-controlled transport to our DHA-licensed laboratory.

UAE Regulatory & Data Privacy Adherence

Regulatory Compliance & Data Protection Framework

All clinical testing and patient data handling at DNA Labs UAE strictly adhere to:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, and storage of personal health information.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating digital health records and telemedicine practices.
Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring patient consent, clinical safety, and professional accountability throughout the diagnostic pathway.

Laboratory operations are conducted under DHA Facility License Number 1143 and ISO 15189:2022 accreditation, guaranteeing international standards of quality and confidentiality.

Clinical & Logistical Metadata

Test Name	Dengue NS1 Antigen EIA (ELISA) Test
Price (AED)	270 AED
Turnaround Time	Same-day report (sample received by 12 noon)
Sample Type / Matrix	Serum or plasma (peripheral venous blood)
Methodology Used	Enzyme-Linked Immunosorbent Assay (ELISA) / Enzyme Immunoassay (EIA)
ICD-10-CM Code	A90, A91
LOINC Code	89979-5
DHA Facility License & Laboratory Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE